Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial thiol-containing proteins are a diverse group of molecules characterized by the presence of reactive sulfhydryl (-SH) groups, primarily located on cysteine residues. These proteins are fundamental to bacterial physiology, serving critical roles in maintaining redox homeostasis, facilitating enzymatic catalysis in metabolic pathways, and ensuring proper protein folding through disulfide bond formation (Fahey, 2013). In the context of infectious diseases, these proteins are essential for bacterial survival and the ability to withstand oxidative stress imposed by the host immune system. Many antimicrobial agents, including heavy metal ions like silver and organomercurials, exert their bactericidal effects by binding to these thiols, which causes widespread protein dysfunction and metabolic collapse (Lemire et al., 2013). Modern drug discovery also explores more selective inhibitors, such as auranofin, which targets specific thiol-dependent enzymes like thioredoxin reductase to treat multi-drug resistant infections (Harbut et al., 2015). Despite their efficacy, the primary challenge in targeting these proteins is achieving selectivity over human thiol-containing proteins to minimize systemic toxicity.
Antimicrobial agents targeting these proteins typically act through covalent modification, S-nitrosylation, or coordination with the sulfhydryl (-SH) group of cysteine residues. This interaction leads to the irreversible inhibition of essential enzymatic activities, disruption of cellular redox balance, and the denaturation of structural proteins, ultimately resulting in bacterial cell death (Lemire et al., 2013; Harbut et al., 2015).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial thiol-containing proteins.